NCT02318186View on ClinicalTrials.gov

Pharmacokinetic Study of Sub-q and IV Treprostinil in Kids With Pulmonary Arterial Hypertension (PAH)

CompletedOBSERVATIONAL
Enrollment

51

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

August 1, 2017

Study Completion Date

August 1, 2017

Conditions
Pulmonary Arterial Hypertension
Trial Locations (1)

94304

Lucille Packard Children's Hospital, Palo Alto

Sponsors

Collaborators (1)

United Therapeutics
All Listed Sponsors
collaborator

United Therapeutics

INDUSTRY

collaborator

Seattle Children's Hospital

OTHER

collaborator

University of Colorado, Denver

OTHER

collaborator

Children's Hospital of Philadelphia

OTHER

lead

Jeffrey A. Feinstein

OTHER